Cargando…
Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD D...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246263/ https://www.ncbi.nlm.nih.gov/pubmed/37293098 http://dx.doi.org/10.21203/rs.3.rs-2944614/v1 |
_version_ | 1785054999068278784 |
---|---|
author | Kearney, Patrick J. Zhang, Yuanxi Tan, Yanglan Kahuno, Elizabeth Conklin, Tucker L. Fagan, Rita R. Pavchinskiy, Rebecca G. Shafer, Scott A. Yue, Zhenyu Melikian, Haley E. |
author_facet | Kearney, Patrick J. Zhang, Yuanxi Tan, Yanglan Kahuno, Elizabeth Conklin, Tucker L. Fagan, Rita R. Pavchinskiy, Rebecca G. Shafer, Scott A. Yue, Zhenyu Melikian, Haley E. |
author_sort | Kearney, Patrick J. |
collection | PubMed |
description | Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression anomalies to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove a progressive motor dysfunction that was more rapid in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreases in DA release, striatal DA content, phenotypic DAergic markers, and a loss of DA neurons, with increased pSer129-alpha synuclein expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss. |
format | Online Article Text |
id | pubmed-10246263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-102462632023-06-08 Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype Kearney, Patrick J. Zhang, Yuanxi Tan, Yanglan Kahuno, Elizabeth Conklin, Tucker L. Fagan, Rita R. Pavchinskiy, Rebecca G. Shafer, Scott A. Yue, Zhenyu Melikian, Haley E. Res Sq Article Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression anomalies to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove a progressive motor dysfunction that was more rapid in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreases in DA release, striatal DA content, phenotypic DAergic markers, and a loss of DA neurons, with increased pSer129-alpha synuclein expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss. American Journal Experts 2023-05-25 /pmc/articles/PMC10246263/ /pubmed/37293098 http://dx.doi.org/10.21203/rs.3.rs-2944614/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Kearney, Patrick J. Zhang, Yuanxi Tan, Yanglan Kahuno, Elizabeth Conklin, Tucker L. Fagan, Rita R. Pavchinskiy, Rebecca G. Shafer, Scott A. Yue, Zhenyu Melikian, Haley E. Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title | Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title_full | Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title_fullStr | Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title_full_unstemmed | Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title_short | Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype |
title_sort | rit2 silencing in dopamine neurons drives a progressive parkinsonian phenotype |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246263/ https://www.ncbi.nlm.nih.gov/pubmed/37293098 http://dx.doi.org/10.21203/rs.3.rs-2944614/v1 |
work_keys_str_mv | AT kearneypatrickj rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT zhangyuanxi rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT tanyanglan rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT kahunoelizabeth rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT conklintuckerl rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT faganritar rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT pavchinskiyrebeccag rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT shaferscotta rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT yuezhenyu rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype AT melikianhaleye rit2silencingindopamineneuronsdrivesaprogressiveparkinsonianphenotype |